IDO1 and glioblastoma: IDO can directly reduce the activation of NK cells in the TME and promote the accumulation of regulatory T cells (Treg) in GBM tumours which go on to secrete immunosuppressive cytokines and inhibitory proteins to further dampen NK cells’ functions [13,18,19].